Clinical Trials List
2024-01-01 - 2027-07-31
Phase II
Recruiting6
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
test
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 李立慈 無
- 連凱華 無
- 鄭皓升 無
- ZHENG-WEI ZHOU 無
- 程稚盛 無
- Cheng-Lun Lai 無
- 林玟君 無
- 謝合原 無
- Chen-Chi Wang 無
- CHENG-HSIEN LIN 無
- 劉時安 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃昭誠 無
- 黃泰霖 無
- 蔡明憲 無
- Tai-Jan Chiu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ku-How Fang 無
- Chung-Jan Kang 無
- 廖俊達 無
- Pei-Wei Huang 無
- Chi-Ting Liau 無
- Li-Yu Lee 無
- 黃祥富 無
- Cheng-Lung Hsu 無
- 葉智華 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yu-Min Liao 無
- Ming-Yu Lien 無
- 陳珈妤 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 高郁勛 無
- 蘇昶瑋 無
- 曾良鵬 無
- 王閔宏 無
- Tzu-Yen Huang 無
- Tsung-Jang Yeh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
92 participants
